Encyclopedia of AIDS

Living Edition
| Editors: Thomas J. Hope, Douglas Richman, Mario Stevenson

HIV Prevention for Stimulant Using Men Who Have Sex with Men

  • Matthew J. Mimiaga
  • Elizabeth F. Closson
  • Amaya Perez-Brumer
  • Jennifer A. Mitty
Living reference work entry
DOI: https://doi.org/10.1007/978-1-4614-9610-6_101-1


HIV and stimulant use are interconnected epidemics among men who have sex with men (MSM) in the USA. Among MSM, stimulant use and its behavioral sequelae are critical targets for interventions across the spectrum of HIV prevention, treatment, and care.

Epidemiologic Profile

HIV Risk Among MSM in the USA

More than 54,000 Americans acquire HIV each year, and men who have sex with men (MSM) represent over half of these new diagnoses. Representing approximately 2.0–5.0 % of the male population in the USA, MSM comprised 68.0 % of adult and adolescent men living with HIV in 2013. In the same year, male-to-male sexual contact was attributable to 65.8 % of new HIV diagnoses in males (CDC 2015). Furthermore, new infections among MSM have remained steady over the past 5 years (2009 = 21,811; 2013 = 21,498; CDC 2015).

Stimulant Use and Sexual Risk-Taking Among MSM in the USA

In the past decade, stimulants, including cocaine/crack, crystal methamphetamine (meth), amphetamines, and...


Cognitive Behavioral Therapy Behavioral Activation Unprotected Anal Intercourse Contingency Management Stimulant Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Benishek LA, Dugosh KL, Kirby KC, Matejkowski J, Clements NT, Seymour BL, et al. Prize-based contingency management for the treatment of substance abusers: a meta-analysis. Addiction. 2014;109:1426–36.CrossRefPubMedPubMedCentralGoogle Scholar
  2. Bourne A. Drug use among men who have sex with men: implications for harm reduction. In: Stoicescu C, editor. Global State of Harm Reduction 2012. London: Harm Reduction International; 2012. p. 147–55.Google Scholar
  3. Brensilver M, Heinzerling KG, Shoptaw S. Pharmacotherapy of amphetamine-type stimulant dependence: an update. Drug Alcohol Rev. 2013;32:449–60.CrossRefPubMedPubMedCentralGoogle Scholar
  4. Colfax G, Shoptaw S. The methamphetamine epidemic: implications for HIV prevention and treatment. Curr HIV/AIDS Rep. 2005;2:194–9.CrossRefPubMedGoogle Scholar
  5. Forrest DW, Metsch LR, LaLota M, Cardenas G, Beck DW, Jeanty Y. Crystal methamphetamine use and sexual risk behaviors among HIV-positive and HIV-negative men who have sex with men in South Florida. J Urban Health. 2010;87:480–5.CrossRefPubMedPubMedCentralGoogle Scholar
  6. Greenwood GL, White EW, Page-Shafer K, Bein E, Osmond DH, Paul J, et al. Correlates of heavy substance use among young gay and bisexual men: the San Francisco Young Men’s Health Study. Drug Alcohol Depend. 2001;61:105–12.CrossRefPubMedGoogle Scholar
  7. Kampman KM. New medications for the treatment of cocaine dependence. Psychiatry. 2005;2:44–8.PubMedPubMedCentralGoogle Scholar
  8. Koblin BA, Murrill C, Camacho M, Xu G, Liu KL, Raj-Singh S, et al. Amphetamine use and sexual risk among men who have sex with men: results from the National HIV Behavioral Surveillance study–New York City. Subst Use Misuse. 2007;42:1613–28.CrossRefPubMedGoogle Scholar
  9. Kosten T, Domingo CB, Orson F, Kinsey B. Vaccines against stimulants: cocaine and MA. Br J Clin Pharmacol. 2014a;77:368–74.CrossRefPubMedPubMedCentralGoogle Scholar
  10. Kosten TR, Domingo CB, Shorter D, Orson F, Green C, Somoza E, et al. Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial. Drug Alcohol Depend. 2014b;140:42–7.CrossRefPubMedPubMedCentralGoogle Scholar
  11. Mansergh G, Colfax GN, Marks G, Rader M, Guzman R, Buchbinder S. The Circuit Party Men’s Health Survey: findings and implications for gay and bisexual men. Am J Public Health. 2001;91:953–8.CrossRefPubMedPubMedCentralGoogle Scholar
  12. Mayer KH, Colfax G, Guzman R. Club drugs and HIV infection: a review. Clin Infect Dis. 2006;42:1463–9.CrossRefGoogle Scholar
  13. Mimiaga MJ, Fair AD, Mayer KH, Koenen K, Gortmaker S, Tetu AM, et al. Experiences and sexual behaviors of HIV-infected MSM who acquired HIV in the context of crystal methamphetamine use. AIDS Educ Prev. 2008;20:30–41.CrossRefPubMedGoogle Scholar
  14. Mimiaga MJ, Reisner SL, Pantalone DW, O’Cleirigh C, Mayer KH, Safren SA. A pilot trial of integrated behavioral activation and sexual risk reduction counseling for HIV-uninfected men who have sex with men abusing crystal methamphetamine. AIDS Patient Care STDS. 2012a;26:681–93.Google Scholar
  15. Mimiaga MJ, Closson EF, Pantalone DW, Taylor SW, Garber M, Safren SA, et al. An open phase pilot of behavioral activation to sustain and enhance the effect of contingency management for reducing stimulant use among HIV-infected patients. Poster presented at the 33rd Annual Meeting & Scientific Sessions of the Society of Behavioral Medicine, 11–14 Apr, New Orleans; 2012b.Google Scholar
  16. Shoptaw S, Reback CJ, Peck JA, Yang X, Rotheram-Fuller E, Larkins S, et al. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Depend. 2005;78:125–34.CrossRefPubMedGoogle Scholar
  17. Spindler HH, Scheer S, Chen SY, Klausner JD, Katz MH, Valleroy LA, et al. Viagra, methamphetamine, and HIV risk: results from a probability sample of MSM, San Francisco. Sex Transm Dis. 2007;34:586–91.PubMedGoogle Scholar
  18. Strathdee SA, Stockman JK. Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Curr HIV/AIDS Rep. 2010;7:99–106.CrossRefPubMedPubMedCentralGoogle Scholar
  19. U.S. Centers for Disease Control and Prevention (CDC). Atlanta: HIV Surveillance Report, 2013; 2015 Feb 82 p. Report No.:25.Google Scholar
  20. Vocci FJ, Montoya ID. Psychological treatments for stimulant misuse, comparing and contrasting those for amphetamine dependence and those for cocaine dependence. Curr Opin Psychiatry. 2009;22:263–8.CrossRefPubMedPubMedCentralGoogle Scholar
  21. Vu NT, Maher L, Zablotska I. Amphetamine-type stimulants and HIV infection among men who have sex with men: implications on HIV research and prevention from a systematic review and meta-analysis. J Int AIDS Soc. 2015;18(1):19273.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2016

Authors and Affiliations

  • Matthew J. Mimiaga
    • 1
    • 2
    • 3
    • 4
    • 5
  • Elizabeth F. Closson
    • 5
    • 6
  • Amaya Perez-Brumer
    • 5
    • 7
  • Jennifer A. Mitty
    • 8
    • 2
  1. 1.Brown University School of Public HealthProvidenceUSA
  2. 2.Brown University Alpert Medical SchoolProvidenceUSA
  3. 3.Brown University Institute for Community Health PromotionProvidenceUSA
  4. 4.Harvard T.H. Chan School of Public HealthBostonUSA
  5. 5.The Fenway Institute, Fenway HealthBostonUSA
  6. 6.The London School of Hygiene and Tropical MedicineLondonUK
  7. 7.Columbia University Mailman School of Public HealthNew YorkUSA
  8. 8.Beth Israel Deaconess Medical Center, Harvard Medical SchoolBostonUSA